Baroni Matteo, Nava Stefano, Giupponi Luca, Meani Paolo, Panzeri Francesco, Varrenti Marisa, Maloberti Alessandro, Soriano Francesco, Agrati Antonio Maria, Ferraro Giovanni, Colombo Fabrizio, Rampoldi Antonio, Mancia Giuseppe, Colombo Paola, Klugmann Silvio, Giannattasio Cristina
Cardiology IV, Cardiovascular "A' De Gasperis" Department, Niguarda Ca' Granda Hospital, Piazza Ospedale Maggiore 3, 20161, Milan, Italy.
Health Science Department, Milan-Bicocca University, Milan, Italy.
High Blood Press Cardiovasc Prev. 2015 Dec;22(4):411-6. doi: 10.1007/s40292-015-0121-4. Epub 2015 Oct 12.
Renal denervation (RD) is an intriguing treatment strategy for resistant hypertension. However, limited data are available about its long time efficacy as well as its effects on intermediate phenotypes like arterial stiffness and carotid IMT. 12 patients (9 males, mean 69 years) with resistant hypertension underwent bilateral RDN (Medtronic System) since April 2012 in Niguarda Ca' Granda Hospital (Milan). Patients were studied before intervention, and at 1, 3, 6 and 12 months after RD. Carotid intima media thickness (Esaote Mylab) and carotid-femoral pulse wave velocity (Complior, Alam medical) were assessed at each step. Compared to baseline, patients showed a marked reduction of office systolic blood pressure at each follow-up step (p < 0.05 versus baseline for all steps) as well as pulse wave velocity (p < 0.01 at 1 year versus baseline). Moreover, reduction in pulse wave velocity was higher than the expected value obtained only considering blood pressure drop. Conversely, no significant effect was observed on diastolic blood pressure as well as carotid intima-media thickness. In our study, renal denervation was a safe and effective procedure. The BP lowering effect was maintained during follow-up and a beneficial effect on arterial stiffness was observed, which implies that this effect can't passively originate from the BP fall but rather from an improvement of arterial mechanical properties, possibly related to a reduced sympathetic arterial drive.
肾去神经支配术(RD)是一种用于治疗顽固性高血压的有趣治疗策略。然而,关于其长期疗效以及对动脉僵硬度和颈动脉内膜中层厚度等中间表型的影响的数据有限。自2012年4月起,在米兰的尼瓜尔达·卡格兰达医院,12例(9例男性,平均年龄69岁)顽固性高血压患者接受了双侧肾去神经支配术(美敦力系统)。在干预前以及肾去神经支配术后1、3、6和12个月对患者进行研究。在每个阶段评估颈动脉内膜中层厚度(百胜Mylab)和颈股脉搏波速度(Complior,阿拉姆医疗公司)。与基线相比,患者在每个随访阶段的诊室收缩压均显著降低(所有阶段与基线相比p<0.05),脉搏波速度也降低(1年时与基线相比p<0.01)。此外,脉搏波速度的降低高于仅考虑血压下降所获得的预期值。相反,未观察到对舒张压以及颈动脉内膜中层厚度有显著影响。在我们的研究中,肾去神经支配术是一种安全有效的手术。随访期间血压降低效果得以维持,并且观察到对动脉僵硬度有有益影响,这意味着这种影响并非被动地源于血压下降,而是源于动脉力学特性的改善,可能与交感神经对动脉的驱动减少有关。